Adults with hypertension and CKD should be treated to a BP goal of less than DBP: C-EO IIa B-R 2. In adults with hypertension and CKD (stage 3 or higher or stage 1 or 2 with albuminuria [ 300 mg/d, or 300 mg/g albumin-to-creatinine ratio or the equivalent in the first morning void]), treatment with an ACE inhibitor is reasonable to slow kidney disease IIb C-EO 3. In adults with hypertension and CKD (stage 3 or higher or stage 1 or 2 with albuminuria [ 300 mg/d, or 300 mg/g albumin-to- creatinine ratio in the first morning void]) (S9.3-7,S9.3-8), treatment with an ARB may be reasonable if an ACE inhibitor is not tolerated. SR indicates systematic review. Synopsis Refer to the Systematic Review for the 2017 ACC/AHA/ AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults for the complete systematic evidence review for additional data and Hypertension is the most common comorbidity affecting patients with CKD. Hypertension has been reported in 67% to 92% of patients with CKD, with increasing preva- lence as kidney function declines.S9.3-14 Hypertension may occur as a result of kidney disease, yet the presence of hyper- tension may also accelerate further kidney injury; therefore, treatment is an important means to prevent further kidney functional decline. 